Abstract

Cockayne syndrome (CS) is a rare premature aging disease, most commonly caused by mutations of the genes encoding the CSA or CSB proteins. CS patients display cachectic dwarfism and severe neurological manifestations and have an average life expectancy of 12 years. The CS proteins are involved in transcription and DNA repair, with the latter including transcription‐coupled nucleotide excision repair (TC‐NER). However, there is also evidence for mitochondrial dysfunction in CS, which likely contributes to the severe premature aging phenotype of this disease. While damaged mitochondria and impaired mitophagy were characterized in mice with CSB deficiency, such changes in the CS nematode model and CS patients are not fully known. Our cross‐species transcriptomic analysis in CS postmortem brain tissue, CS mouse, and nematode models shows that mitochondrial dysfunction is indeed a common feature in CS. Restoration of mitochondrial dysfunction through NAD+ supplementation significantly improved lifespan and healthspan in the CS nematodes, highlighting mitochondrial dysfunction as a major driver of the aging features of CS. In cerebellar samples from CS patients, we found molecular signatures of dysfunctional mitochondrial dynamics and impaired mitophagy/autophagy. In primary cells depleted for CSA or CSB, this dysfunction can be corrected with supplementation of NAD+ precursors. Our study provides support for the interconnection between major causative aging theories, DNA damage accumulation, mitochondrial dysfunction, and compromised mitophagy/autophagy. Together, these three agents contribute to an accelerated aging program that can be averted by cellular NAD+ restoration.

Highlights

  • Patients with Cockayne syndrome (CS) experience cachectic dwarfism and microcephaly, with an average life expectancy of 12 years

  • We found that the terms associated with synaptic transmission, cellular signaling, membrane formation, lysosome, and mitochondria were the only Gene Ontology (GO) terms that are commonly affected in all CS models and CS brain samples (Figure 1f)

  • To assess the pathways that are specially targeted by NAD+ supplementation, we examined the Z-score of individual GO terms that were altered in CS models but restored with nicotinamide riboside (NR) treatment

Read more

Summary

| INTRODUCTION

Patients with Cockayne syndrome (CS) experience cachectic dwarfism and microcephaly, with an average life expectancy of 12 years. Rapamycin treatment or dietary restriction, which up-regulate mitophagy, has shown promise in CS models (Scheibye-Knudsen et al, 2012) It is of interest whether increasing NAD+ levels through NAD+ precursor supplementation can ameliorate symptoms of mitochondrial dysfunction in CS. Cellular and tissue NAD+ supplementation restored the activity of these proteins in primary cell lines deficient in CSA or CSB. This has implications for intervention in CS and possibly aging

| RESULTS
| DISCUSSION
Findings
| METHODS

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.